Wockhardt, on Monday, reported a consolidated net profit of Rs.334.76 crore for the fourth quarter ended March 31, 2013, mainly on the back of robust international sales, against a net loss of Rs.191.64 crore in the year-ago period.
Net sales stood at Rs.1,485.50 crore against Rs.1,175.60 crore. International business contributed 83 per cent of the total revenues.
Consolidated net profit for the year ended March 31, 2013, stood at Rs.1,594.12 crore against Rs.342.71 crore. Net sales rose to Rs.5,609.42 crore from Rs.4,350.50 crore in 2011-12.
The board has recommended a dividend of Rs.5 per share of Rs.5 each for 2012-13. It also recommended a dividend of 0.01 per cent (Rs.0.0005 per preference share of Rs.5 each), absorbing a sum of Rs.2,98,557 on 475,659,941 non-convertible cumulative redeemable preference shares of Rs.5 each and 121,454,927 optionally-convertible cumulative redeemable preference shares of Rs.5 each.
TTK Healthcare
TTK Healthcare reported a 39.6 per cent decline in its net profit at Rs.2.24 crore for the fourth quarter ended March 31, 2013, against Rs.3.71 crore in the year-ago period. Total income from operations declined to Rs.85.91 crore from Rs.88.07 crore.
For the year ended March 31, 2013, the net profit dipped by 9 per cent to Rs.14.20 crore from Rs.15.62 crore in 2011-12. Total income from operations rose to Rs.382.29 crore from Rs.353.74 crore.
The board has recommended a dividend of Rs.4 per share of Rs.10 each for 2012-13.
Gujarat NRE Coke
Gujarat NRE Coke returned to profitability in the fourth quarter ended March 31, 2013, with a net profit of Rs.5.15 crore against a net loss of Rs.45.51 crore during the year-ago period. The company managed to reduce its costs significantly during the quarter even though its net sales declined marginally by 0.74 per cent to Rs.327.98 crore, it said in a filing to the BSE.
A sharp decrease in expenses during the last quarter also negated the impact of over 37 per cent rise in Gujarat NRE’s interest outgo at Rs.63.13 crore. The company also incurred an exceptional loss of Rs.9.63 crore due to forex losses.
For the full year ended March 31, 2013, its net profit rose to Rs.30.97 crore vis-a-vis Rs 3.09 crore. Its net sales, at Rs.1,713.04 crore, were up nearly 25 per cent in the last fiscal.
Shares of the company closed on Monday at Rs.17.20 apiece on the BSE, up 0.88 per cent from the previous close.
Himadri Chemicals
Himadri Chemicals and Industries, a speciality carbon company, has registered a 20.8 per cent jump in its net profit at Rs.26.9 crore during the fourth quarter ended March 31, 2013, against Rs.22.2 crore in the year-ago period.
Net sales, however, declined by 8.4 per cent to Rs.301.8 crore from Rs.329.4 crore, according to a company release.
The company said it has registered 18.2 percent increase in consolidated net sales at Rs.1,353.3 crore in 2012-13 as against Rs.1,144.8 crore in 2011-12. The net profit, however, slipped by 83.5 per cent to Rs.9.4 crore from Rs.57.3 crore.
